Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Ariad Pharmaceuticals and AVEO Pharmaceuticals

Continue Reading

Gold Futures Surge to 1 Month Highs on Optimism That the Upcoming “Fiscal Cliff” Can Be Avoided

The Paragon Report Provides Stock Research on Newmont Mining and Goldcorp

Continue Reading

U.S. Foreign Oil Imports Projected to Decline by More Than 50% Within the Next Decade

The Paragon Report Provides Stock Research on Forest Oil and Petroquest Energy

Continue Reading

FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011

Five Star Equities Provides Stock Research on CytRx and ZIOPHARM Oncology

Continue Reading

U.S. Foreign Oil Imports Projected to Decline by More Than 50% Within the Next Decade

The Paragon Report Provides Stock Research on Bill Barrett and EXCO Resources

Continue Reading

FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011

Five Star Equities Provides Stock Research on Astex Pharmaceuticals and Amicus Therapeutics

Continue Reading

Gold Stocks Receive Boost as Gold Futures Surges to 1-Month High

The Paragon Report Provides Stock Research on AuRico Gold and NovaGold Resources

Continue Reading

Gold Futures Reach 1-Month High as Lawmakers Seek to Find Solution for Upcoming “Fiscal Cliff”

The Paragon Report Provides Stock Research on Kinross Gold and Yamana Gold

Continue Reading

Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Amgen and Regeneron Pharmaceuticals

Continue Reading

Analysts Predict Bullish Short-Term Outlook for Gold as Lawmakers Look to Avoid “Fiscal Cliff”

The Paragon Report Provides Stock Research on Eldorado Gold and New Gold

Continue Reading